BioGend Therapeutics Co., Ltd. (TPEX: 6733)
Taiwan
· Delayed Price · Currency is TWD 37.00
+0.40 (1.09%)
Sep 11, 2024, 9:20 AM CST
BioGend Therapeutics Company Description
BioGend Therapeutics Co., Ltd. develops regenerative bio-orthopaedic products.
It is developing BiG-001 and BiG-006, an osteoinductive bone graft substitute; and BiG-009, an autologous cartilage repair system.
The company was founded in 2016 and is based in Taipei, Taiwan.
BioGend Therapeutics Co., Ltd.
| Country | Taiwan |
| Founded | 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
Contact Details
Address: No.3-2, Park Street Taipei, 115 Taiwan | |
| Phone | 886 2 2655 8366 |
| Website | biogend.com |
Stock Details
| Ticker Symbol | 6733 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 2836 |